{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T23:11:57Z","timestamp":1784157117828,"version":"3.55.0"},"reference-count":42,"publisher":"European Respiratory Society (ERS)","issue":"4","license":[{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS-15-59-31839"],"award-info":[{"award-number":["FS-15-59-31839"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RE\/18\/4\/34215"],"award-info":[{"award-number":["RE\/18\/4\/34215"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RG\/10\/16\/28575"],"award-info":[{"award-number":["RG\/10\/16\/28575"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["SP\/12\/12\/29836"],"award-info":[{"award-number":["SP\/12\/12\/29836"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/K020919\/1"],"award-info":[{"award-number":["MR\/K020919\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000691","name":"Academy of Medical Sciences","doi-asserted-by":"publisher","award":["SBF004\\1095"],"award-info":[{"award-number":["SBF004\\1095"]}],"id":[{"id":"10.13039\/501100000691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2020,9,20]]},"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:p>Pulmonary hypertension is a condition with limited effective treatment options. Chronic thromboembolic pulmonary hypertension (CTEPH) is a notable exception, with pulmonary endarterectomy (PEA) often proving curative. This study investigated the plasma metabolome of CTEPH patients, estimated reversibility to an effective treatment and explored the source of metabolic perturbations.<\/jats:p><jats:p>We performed untargeted analysis of plasma metabolites in CTEPH patients compared to healthy controls and disease comparators. Changes in metabolic profile were evaluated in response to PEA. A subset of patients were sampled at three anatomical locations and plasma metabolite gradients calculated.<\/jats:p><jats:p>We defined and validated altered plasma metabolite profiles in patients with CTEPH. 12 metabolites were confirmed by receiver operating characteristic analysis to distinguish CTEPH and both healthy (area under the curve (AUC) 0.64\u20130.94, all p&lt;2\u00d710<jats:sup>\u22125<\/jats:sup>) and disease controls (AUC 0.58\u20130.77, all p&lt;0.05). Many of the metabolic changes were notably similar to those observed in idiopathic pulmonary arterial hypertension (IPAH). Only five metabolites (5-methylthioadenosine, N1-methyladenosine, N1-methylinosine, 7-methylguanine, N-formylmethionine) distinguished CTEPH from chronic thromboembolic disease or IPAH. Significant corrections (15\u2013100% of perturbation) in response to PEA were observed in some, but not all metabolites. Anatomical sampling identified 188 plasma metabolites, with significant gradients in tryptophan, sphingomyelin, methionine and Krebs cycle metabolites. In addition, metabolites associated with CTEPH and gradients showed significant associations with clinical measures of disease severity.<\/jats:p><jats:p>We identified a specific metabolic profile that distinguishes CTEPH from controls and disease comparators, despite the observation that most metabolic changes were common to both CTEPH and IPAH patients. Plasma metabolite gradients implicate cardiopulmonary tissue metabolism of metabolites associated with pulmonary hypertension and metabolites that respond to PEA surgery could be a suitable noninvasive marker for evaluating future targeted therapeutic interventions.<\/jats:p>","DOI":"10.1183\/13993003.03201-2020","type":"journal-article","created":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T19:05:15Z","timestamp":1602788715000},"page":"2003201","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":41,"title":["Plasma metabolomics exhibit response to therapy in chronic thromboembolic pulmonary hypertension"],"prefix":"10.1183","volume":"57","author":[{"given":"Emilia M.","family":"Swietlik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavandeep","family":"Ghataorhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasia I.","family":"Zalewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wharton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke S.","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Taboada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"UK National Cohort Study of PAH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas W.","family":"Morrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3926-1171","authenticated-orcid":false,"given":"Martin R.","family":"Wilkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3969-6143","authenticated-orcid":false,"given":"Mark","family":"Toshner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Pepke-Zaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Rhodes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2020,10,15]]},"reference":[{"key":"2024102102022314000_57.4.2003201.1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01032-2015"},{"key":"2024102102022314000_57.4.2003201.2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.019470"},{"key":"2024102102022314000_57.4.2003201.3","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.00000815"},{"key":"2024102102022314000_57.4.2003201.4","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00288.2016"},{"key":"2024102102022314000_57.4.2003201.5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.024602"},{"key":"2024102102022314000_57.4.2003201.6","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01915-2018"},{"key":"2024102102022314000_57.4.2003201.7","doi-asserted-by":"publisher","DOI":"10.1021\/ac901536h"},{"key":"2024102102022314000_57.4.2003201.8","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2013.0010"},{"key":"2024102102022314000_57.4.2003201.9","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2116\/analsci.28.801","article-title":"Quantile normalization approach for liquid chromatography-mass spectrometry-based metabolomic data from healthy human volunteers","volume":"28","author":"Lee","year":"2012","journal-title":"Anal Sci"},{"key":"2024102102022314000_57.4.2003201.10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11306-018-1335-y","article-title":"From correlation to causation: analysis of metabolomics data using systems biology approaches","volume":"14","author":"Rosato","year":"2018","journal-title":"Metabolomics"},{"key":"2024102102022314000_57.4.2003201.11","doi-asserted-by":"publisher","DOI":"10.1002\/jso.2930140313"},{"key":"2024102102022314000_57.4.2003201.12","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.cmet.2018.09.022","article-title":"Profound perturbation of the metabolome in obesity is associated with health risk","volume":"29","author":"Cirulli","year":"2019","journal-title":"Cell Metab"},{"key":"2024102102022314000_57.4.2003201.13","first-page":"271","article-title":"Integrated metabolomics and proteomics highlight altered nicotinamide- and polyamine pathways in lung adenocarcinoma","volume":"38","author":"Fahrmann","year":"2017","journal-title":"Carcinogenesis"},{"key":"2024102102022314000_57.4.2003201.14","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1210\/jc.2019-00822","article-title":"Purine metabolites and carnitine biosynthesis intermediates are biomarkers for incident type 2 diabetes","volume":"104","author":"Ottosson","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2024102102022314000_57.4.2003201.15","doi-asserted-by":"crossref","first-page":"e001927","DOI":"10.1161\/CIRCGEN.118.001927","article-title":"Dawn of epitranscriptomic medicine","volume":"11","author":"Gatsiou","year":"2018","journal-title":"Circ Genom Precis Med"},{"key":"2024102102022314000_57.4.2003201.16","doi-asserted-by":"publisher","DOI":"10.1086\/686011"},{"key":"2024102102022314000_57.4.2003201.17","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00007309"},{"key":"2024102102022314000_57.4.2003201.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2017.03.005"},{"key":"2024102102022314000_57.4.2003201.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2004.05.017"},{"key":"2024102102022314000_57.4.2003201.20","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/ajcn\/77.3.700","article-title":"Mixed tocopherols inhibit platelet aggregation in humans: potential mechanisms","volume":"77","author":"Liu","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"2024102102022314000_57.4.2003201.21","doi-asserted-by":"crossref","first-page":"e0176887","DOI":"10.1371\/journal.pone.0176887","article-title":"Oxidative profiling of the failing right heart in rats with pulmonary hypertension","volume":"12","author":"Wang","year":"2017","journal-title":"PLoS One"},{"key":"2024102102022314000_57.4.2003201.22","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.10012"},{"key":"2024102102022314000_57.4.2003201.23","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707383"},{"key":"2024102102022314000_57.4.2003201.24","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)38000-1"},{"key":"2024102102022314000_57.4.2003201.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7827(01)00003-0"},{"key":"2024102102022314000_57.4.2003201.26","doi-asserted-by":"crossref","first-page":"2045894019890553","DOI":"10.1177\/2045894019890553","article-title":"Plasma metabolomic profile in chronic thromboembolic pulmonary hypertension","volume":"10","author":"Heresi","year":"2020","journal-title":"Pulm Circ"},{"key":"2024102102022314000_57.4.2003201.27","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1513\/AnnalsATS.201504-236LE","article-title":"Increased right ventricular fatty acid accumulation in chronic thromboembolic pulmonary hypertension","volume":"12","author":"Sakao","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"2024102102022314000_57.4.2003201.28","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aao4583"},{"key":"2024102102022314000_57.4.2003201.29","doi-asserted-by":"publisher","DOI":"10.4103\/2045-8932.97606"},{"key":"2024102102022314000_57.4.2003201.30","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201108-1536PP"},{"key":"2024102102022314000_57.4.2003201.31","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00109-014-1244-0","article-title":"Skeletal muscle proteomic signature and metabolic impairment in pulmonary hypertension","volume":"93","author":"Malenfant","year":"2015","journal-title":"J Mol Med"},{"key":"2024102102022314000_57.4.2003201.32","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.115.301130"},{"key":"2024102102022314000_57.4.2003201.33","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3001006"},{"key":"2024102102022314000_57.4.2003201.34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1703338114"},{"key":"2024102102022314000_57.4.2003201.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.10.072"},{"key":"2024102102022314000_57.4.2003201.36","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.019351"},{"key":"2024102102022314000_57.4.2003201.37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0234404"},{"key":"2024102102022314000_57.4.2003201.38","doi-asserted-by":"crossref","unstructured":"Shimada YJ , Batra J , Kochav SM , et al. Difference in metabolomic response to exercise between patients with and without hypertrophic cardiomyopathy. J Cardiovasc Transl Res 2020; in press [https:\/\/doi.org\/10.1007\/s12265-020-10051-2]. doi:10.1007\/s12265-020-10051-2.","DOI":"10.1007\/s12265-020-10051-2"},{"key":"2024102102022314000_57.4.2003201.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.04.083"},{"key":"2024102102022314000_57.4.2003201.40","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.3390\/ijms19092499","article-title":"Consequences of BMPR2 deficiency in the pulmonary vasculature and beyond: contributions to pulmonary arterial hypertension","volume":"19","author":"Andruska","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2024102102022314000_57.4.2003201.41","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1165\/rcmb.2015-0404LE","article-title":"Gut\u2013lung connection in pulmonary arterial hypertension","volume":"56","author":"Ranchoux","year":"2017","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2024102102022314000_57.4.2003201.42","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1161\/HYPERTENSIONAHA.119.14294","article-title":"Altered gut microbiome profile in patients with pulmonary arterial hypertension","volume":"75","author":"Kim","year":"2020","journal-title":"Hypertension"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.03201-2020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:30:06Z","timestamp":1740375006000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.03201-2020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,15]]},"references-count":42,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,1]]},"published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1183\/13993003.03201-2020"],"URL":"https:\/\/doi.org\/10.1183\/13993003.03201-2020","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,15]]}}}